CIK: 0001388551 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $39,150 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SVRA | SAVARA INC | 6,896,551 | $10,690 | 27.3% | $1.66 | -17.6% | COM | 805111101 |
| XERS | XERIS BIOPHARMA HOLDINGS INC | 6,039,028 | $8,032 | 20.5% | $2.16 | -34.6% | COM | 98422E103 |
| SPY | SPDR S&P 500 ETF TR | 15,947 | $6,099 | 15.6% | $451.81 | — | TR UNIT | 78462F103 |
| RZLT | REZOLUTE INC | 1,403,157 | $2,905 | 7.4% | $9.52 | -80.3% | COM NEW | 76200L309 |
| SCYX | SCYNEXIS INC | 1,723,947 | $2,689 | 6.9% | $6.13 | -63.9% | COM NEW | 811292200 |
| XOP | SPDR SER TR | 17,500 | $2,378 | 6.1% | $124.74 | — | S&P OILGAS EXP | 78468R556 |
| — | VECTIVBIO HLDG AG | 156,222 | $1,346 | 3.4% | $5.72 | — | ORD SHS | H9060V101 |
| ACLX | ARCELLX INC | 36,302 | $1,125 | 2.9% | $16.24 | +41.3% | COMMON STOCK | 03940C100 |
| AMLP | ALPS ETF TR | 29,500 | $1,123 | 2.9% | $36.58 | — | ALERIAN MLP | 00162Q452 |
| CMPX | COMPASS THERAPEUTICS INC | 211,159 | $1,062 | 2.7% | $3.99 | 0.0% | COM | 20454B104 |
| CABA | CABALETTA BIO INC | 84,728 | $784 | 2.0% | $3.64 | 0.0% | COM | 12674W109 |
| — | MOLECULAR TEMPLATES INC | 2,052,991 | $673 | 1.7% | $8.09 | — | COM | 608550109 |
| — | ALLAKOS INC | 18,271 | $154 | 0.4% | $8.42 | — | COM | 01671P100 |
| — | ELEVATION ONCOLOGY INC | 68,324 | $65 | 0.2% | $9.95 | — | COM | 28623U101 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 21,333 | $18 | 0.0% | $0.83 | — | *W EXP 11/22/202 | N62509117 |
| — | BRIDGETOWN HOLDINGS LTD | 39,773 | $5 | 0.0% | $4.40 | — | *W EXP 09/30/202 | G1355U121 |
| LANV/WS | LANVIN GROUP HOLDINGS LIMITE | 12,000 | $4 | 0.0% | $0.31 | — | *W EXP 99/99/999 | G5380J118 |